Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
They are not supplied as medicines, treatments, substitutes, supplements, cosmetic products or personal-use products
Australia expands at 12.5%, driven by telehealth adoption and demand for improved access across remote regions
Discover the differences between probiotics and GLP-1 agonists for blood sugar and weight management
For background and actionable strategies, see: Leaky Gut Syndrome: Causes, Symptoms, and Functional Medicine Solutions and How to Repair Intestinal Mucosal Integrity
The guidelines state, GLP-1 RAs may be considered for weight-loss in patients who have completed cancer therapy and may be considered with caution for patients on stable endocrine-based cancer therapies based on limited observational safety data. They also say, GLP-1 RAs cannot be recommended currently for patients receiving or initiating chemotherapies and/or immunotherapies due to lack of safety and outcomes data. Iyengar is director of Survivorship Services at Winship Cancer Institute of Emory University, a clinical member of Winships Glenn Family Breast Center, an associate professor and co-director of the Breast Medical Oncology Program in the Department of Hematology and Medical Oncology at Emory University School of Medicine, and co-editor-in-chief of the journal ONCOLOGY
